Back to 
Carlyle Group Inc.
Carlyle Group Inc.
JSPR
Showing 0 of 5 quarters
Position history for Carlyle Group Inc.'s holdings in Jasper Therapeutics, Inc.
As of its Q4 2023 13F, Carlyle Group held 8,761,891 shares of JSPR (Jasper Therapeutics), worth $6.7M. Carlyle Group's 13F filings listed JSPR from Q1 2023 to Q4 2023, 4 quarterly filings. JSPR was 0.3% of Carlyle Group's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.